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Abstract
OBJECTIVES—Primary care providers often care for men with prostate cancer due to its
prolonged clinical course and an increasing number of survivors. However, their attitudes and care
patterns are inadequately studied. In this context, we surveyed primary care providers regarding
the scope of their prostate cancer survivorship care.
METHODS—The 2006 Early Detection and Screening for Prostate Cancer Knowledge, Attitudes
and Practice Survey conducted by the Michigan Public Health Institute investigated the beliefs and
practice patterns of primary care providers in Michigan. We evaluated responses from 902
primary care providers regarding the timing and content of their prostate cancer survivorship care
and relationships with specialty care.
RESULTS—Two-thirds (67.6%) of providers cared for men during and after prostate cancer
treatment. Providers routinely inquired about incontinence, impotence and bowel problems
(83.3%), with a few (14.2%) using surveys to measure symptoms. However, only a minority felt
‘very comfortable’ managing the side effects of prostate cancer treatment. Clear plans (76.1%) and
details regarding management of treatment complications (65.2%) from treating specialists were
suboptimal. Nearly one-half (45.1%) of providers felt it was equally appropriate for them and
treating specialists to provide prostate cancer survivorship care.
CONCLUSIONS—Primary care providers reported that prostate cancer survivorship care is
prevalent in their practice, yet few felt very comfortable managing side effects of prostate cancer
© 2011 Elsevier Inc. All rights reserved.
Corresponding Author: John T. Wei, MD, MS Professor of Urology Department of Urology The University of Michigan Room
1021, Michigan House 2301 Commonwealth Blvd. Ann Arbor, MI 48105-2967 Tel: 734-615-3040 jtwei@med.umich.edu.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Urol Oncol. Author manuscript; available in PMC 2014 August 01.
Published in final edited form as:













treatment. To improve quality of care, implementing prostate cancer survivorship care plans
across specialties, or transferring primary responsibility to primary care providers through
survivorship guidelines, should be considered.
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INTRODUCTION
With over 2 million survivors and nearly $7 billion in national health expenditures annually,
prostate cancer is one of the most prevalent and expensive cancers in the U.S.1,2 Under
current screening practices, 1 out of 6 men will be diagnosed with the disease during their
lifetime.3 The downstream consequences of that diagnosis may include significant
detriments to urinary control, sexual function and overall quality of life.4 Because the
disease and side effects of its treatment are so common, understanding how to optimize the
delivery of prostate cancer survivorship care has significant quality of care implications.
Due to the prolonged natural history of the disease and the sheer number of prostate cancer
survivors, primary care providers inevitably care for these men. However, their role in
prostate cancer survivorship care remains undefined. The timing, content, and processes of
prostate cancer survivorship care among primary care providers have been understudied. For
example, how they care for treatment-related side effects (incontinence, impotence) or
address other prostate cancer survivorship issues is largely unknown. Moreover, primary
care and oncology specialties have not established a consensus on who is responsible for
routine survivorship care (i.e., monitoring for disease recurrence, treating side effects,
counseling regarding general health, and screening for other malignancies).5 Such
uncertainty fosters fragmented care potentially leading to duplicate services,6 patient
inconvenience, and increased cost.7,8
Describing primary care provider involvement during prostate cancer survivorship may help
identify opportunities to improve care coordination and optimize quality of care. Therefore,
the Michigan Cancer Consortium, a state-wide non-profit collaborative of cancer care
institutions and the Michigan Public Health Institute, surveyed primary care providers in the




The Early Detection and Screening for Prostate and Colorectal Cancer Knowledge, Attitudes
and Practice (KAP) Survey was developed by the Michigan Public Health Institute in
collaboration with primary care providers, urologists, radiation oncologists, medical
oncologists, and nurses affiliated with the Prostate Cancer Action Committee of the
Michigan Cancer Consortium.9 The survey was intended to characterize the following
aspects of prostate cancer survivorship care by primary care providers: 1) the types of
prostate cancer care delivered; 2) the degree of communication with treating specialists
regarding their patients’ survivorship care; 3) the comfort level with treating survivors’
incontinence, impotence, bowel problems and psychosocial concerns; 4) preferred
treatments (e.g., medication, referral) for managing prostate cancer treatment-related side
effects; 5) opinions of who is the most appropriate to provide survivorship care (i.e., primary
care provider, treating specialist, survivorship clinic); and 6) the degree to which they
addressed urinary and sexual symptoms during survivorship. All survey data were entered
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into a central database maintained at the Michigan Public Health Institute. Informed consent
from each of the respondents was obtained. The Institutional Review Boards of the
Michigan Public Health Institute and the Michigan Department of Community Health
approved the study.
Study Population
In 2006, the KAP survey was mailed in a staggered fashion to all primary care providers and
a random sample of nurse practitioners and physician assistants licensed to practice in the
State of Michigan. Primary care provider addresses were identified from a state-wide
database maintained by a private vendor and verified using data from the Michigan Bureau
of Health Professionals. Addresses for nurse practitioners and physician assistants were
obtained from the State of Michigan's Licensing Division. The survey included a cover letter
describing the purpose of the study as well as entry into a drawing for a cash prize of $575
as an incentive. Recipients were instructed to return the survey within two weeks and up to
two reminder postcards were sent out.
The survey was completed by 902 of an estimated 5,687 eligible respondents (15.9%
response rate). Due to the sampling frame, the majority of the primary care provider
respondents were physicians (74.3%). Primary care nurse practitioners had the greatest the
response rate (n=121, 18.3%), followed by physicians (n=670, 15.7%) and physician
assistants (n=111, 14.3%).
Statistical Analysis
To determine the response percentage for each item, the total number of responses per
survey item was used as the denominator. Descriptive statistics were used to evaluate the
characteristics of primary care providers and their practices. To ascertain whether
differences in comfort levels managing prostate cancer treatment-related side effects existed
among the 3 primary care provider types (physician, nurse practitioner and physician
assistant), we used the Mantel-Haenszel chi-square test.
RESULTS
As shown in Table 1, just over half of primary care providers responding to the survey were
male (53.7%), most were white (83.8%), and nearly two-thirds (64.8%) were over the age of
45. Among respondents, two-thirds (67.6%) cared for men following a diagnosis of prostate
cancer.
While the timing and content of their cancer care varied, primary care providers reported
that they were involved in a wide variety of prostate cancer survivorship care.
Approximately two-thirds participated in treatment decision making (64.5%) and symptom
management during active treatment (63.4%). Moreover, the rate of post-treatment symptom
management rose to 83.0%, with three-quarters (78.4%) of primary care providers reporting
that they performed periodic monitoring for their prostate cancer survivors. Nearly all
primary care providers believed that patients were receiving follow up care with their
treating specialist during the first year after treatment (98.3%).
As shown in Table 2, only a minority of primary care providers felt ‘very comfortable’
managing the side effects of prostate cancer treatment. Although there were no differences
between the comfort levels of physicians, nurse practitioners and physician assistants with
treating urinary incontinence (p=0.09), differences in comfort levels did exist among various
providers when treating impotence (p=0.02), bowel problems (p=0.01) and psychosocial
concerns (p=0.02). In addition to prescribing anticholinergics (74.8%) and erectile
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dysfunction medications (89.3%), referrals to urologists for the treatment of incontinence
(89.6%) and impotence (84.0%) were common among primary care providers.
Despite a lack of comfort with treating prostate cancer treatment-related side effects,
providers appeared comfortable asking about them. For example, the majority of providers
routinely inquired about survivors’ incontinence, impotence and bowel problems (83.3%) –
although only 14.2% used surveys or questionnaires to measure urinary and sexual
symptoms. In addition, nearly all providers kept prostate cancer as a diagnosis on the
patient's active issue list (97.2%). In terms of oncologic processes of care, primary care
providers reported routinely recommending referral back to specialists for a rising PSA
(99.3%) or per patient request (97.2%).
As illustrated in Figure 1, nearly one-half (45.1%) of primary care providers felt it was
equally appropriate for them and the treating specialists to provide prostate cancer care for
survivors. Only 3.5% of primary care providers believed their specialty was the most
appropriate to provide survivorship care, while 13.3% felt comprehensive survivorship
clinics were the most appropriate. Among primary care providers caring for prostate cancer
survivors, communication from treating specialists was fair. Adequate communication
(81.2%), clear treatment plans (76.1%), and details regarding treatment complications and
their management (65.2%) were not standard practice.
DISCUSSION
Primary care providers play a significant role in prostate cancer survivorship care during and
beyond treatment. Their comfort levels managing prostate cancer treatment side effects
varied in our study, with most being only somewhat comfortable treating common treatment
sequelae regardless of provider type. This may relate to the fact that communication,
planning, and treatment recommendations from the treating specialists were limited,
especially regarding side effect management. Although the vast majority of primary care
providers did inquire about treatment-related symptoms, systematic approaches to
evaluating urinary and sexual symptoms using validated measures were scant. On average,
primary care providers believe they are appropriate caregivers for prostate cancer survivors.
Because more men will be diagnosed with prostate cancer as the population ages,10 primary
care providers may need to increasingly participate in survivorship care.11
Providing quality prostate cancer survivorship care involves adequate monitoring for
recurrent disease, effectively treating any side effects following the diagnosis, and
promoting a healthy lifestyle.11 Respondents indicated that they understood the basic
oncologic principle of prostate cancer surveillance by near universal referral to treating
specialists in the setting of a rising PSA (a marker of disease recurrence and progression
following treatment). However, this survey did not inquire about what providers believed
was an appropriate threshold PSA level consistent with disease progression after treatment.
Further study is needed to understand whether primary care providers understand the
expected PSA levels following definitive therapy (i.e., undetectable after surgery; declining
levels to a nadir after radiation). These findings would have important implications as early
salvage therapy can be associated with improved survival.12
Although confidence in their treatments varied, primary care providers commonly used
anticholinergics and phosphodiesterase type 5 inhibitors to treat survivors’ incontinence and
impotence, respectively. These are acceptable treatments in most cases; however, primary
care providers also made frequent referrals to urologists to further investigate such
symptoms. Urologist referral for commonly encountered, relatively straightforward side
effects appeared to be excessive, perhaps indicating that primary care providers need more
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guidance to care for prostate cancer survivors. In addition, most providers reported that they
did not use validated instruments to understand whether their treatments were successful.
Easily administered surveys such as the Incontinence Symptom Index13 and the
International Index of Erectile Function14 to track progress before and during treatment
would allow providers to better understand how survivors’ symptoms are being managed.
These are commonly used in urologic practice and might also inform the communication
gap noted by providers in this study with respect to survivorship care. Finally, primary care
providers are probably the best suited specialty to promote healthy lifestyles for prostate
cancer survivors. Overall, they are well-positioned to provide quality prostate cancer
survivorship care, but may need further direction from treating specialist physicians.
Underlying these findings is the absence of prostate cancer clinical practice guidelines and
survivorship care plans to guide primary care providers caring for prostate cancer survivors.
Primary care providers indicate that with appropriate information, guidance and efficient
processes in place for re-referral and investigation of potential recurrences they would be
able to assume greater responsibility for cancer survivorship care.15 The Institute of
Medicine's landmark report From Cancer Patient to Cancer Survivor: Lost in Transition
notes the fundamental need for survivorship care plans and improved care coordination to
improve the quality of cancer care.16 Highlighted in such a plan would be a summary of the
critical information needed for the survivor's long-term care. For example, the cancer type
and treatment, treatment-related side effects and their management, information regarding
surveillance (i.e., PSA testing), and survey instruments to monitor urinary and sexual
symptoms. Last, accountability for various aspects of survivorship care would also be
outlined.16
Communicating survivorship care plans may improve survivorship quality of care among
primary care providers through addressing the gaps identified in this study. In response to
the findings of this survey and to improve the transfer of care from specialty to primary care,
the Michigan Cancer Consortium Prostate Cancer Action Committee created guidelines for
primary care physicians to help them manage prostate cancer treatment sequelae (http://
www.michigancancer.org/PDFs/MCCGuidelines-PrimaryCareMgtProstateCaPost-
TxSequelae.pdf).17 These publically available survivorship management guidelines may be
especially important given that providers reported little interest in comprehensive
survivorship clinics for their prostate cancer patients. For example, the incontinence portion
of the guidelines provides a list of patient self-management strategies (e.g., monitoring fluid
intake, weight loss), medical therapies (e.g., anticholinergics, Kegel exercises and pelvic
floor physical therapy) as well as surgical options necessitating urologist referral (e.g.,
bulking agents, urethral sling) to help providers manage incontinence following surgery or
radiation therapy. Better understanding how best to incorporate these guidelines into
practice is needed. Support from the Society of Urologic Oncology, American Urological
Association, the American Cancer Society and the American Society for Radiation
Oncology for better education of primary care providers (including nurse practitioners and
physician assistants) might improve the co-management of prostate cancer patients during
and after definitive care.
The results of this study are from primary care providers in the State of Michigan, not a
national sample. Nonetheless, we did include physicians, nurse practitioners and physician
assistants to increase the generalizability of the findings. In addition, it is unlikely that
primary care providers in Michigan are fundamentally different than those from other states.
Next, the data are based on the self reported beliefs and practice patterns of primary care
providers, not necessarily the survivorship care that patients actually receive. However, to
the extent that attitudes and beliefs contribute to provider behavior, we would expect that
improving various aspects of prostate cancer survivorship care in Michigan is warranted.18
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The response rate of this study is insufficient to generalize with confidence due to possible
selection bias, although not entirely uncommon for a physician survey.19 On the other hand,
the degree of varying opinions and comfort levels among this sample of over 600 primary
care providers treating prostate cancer survivors is unlikely to diminish with a larger sample
size. Moreover, these data suggest that a substantial proportion of primary care providers
may be prepared to assume primary responsibility and would welcome guidance regarding
survivorship care. Whether the primary care workforce could tolerate the increased
workload is unclear; however, it appears that many are already dealing with prostate cancer
survivor issues. Given the lack of current resources to direct prostate cancer survivorship
care, more education for both the urologic and primary care community seems warranted.
Primary care providers reported that prostate cancer survivorship care is prevalent in their
practice. Since nearly all believed the specialist remained the primary treating physician, the
primary care role appears to be an adjunct to specialty care early in survivorship. To
improve quality of care and coordination, one option would be to implement prostate cancer
survivorship care plans across specialties. An alternative is to transfer responsibility for
prostate cancer survivorship care to the portion of primary care providers who express
comfort with primary responsibility. Good communication with treating specialists, the use
of existing standardized assessment tools and post-treatment guidelines or care plans may
lead to improved quality of care for men with prostate cancer.
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Figure 1. Primary care provider opinions regarding who is most appropriate to provide prostate
cancer survivorship care
Pie chart representing responses from primary care providers who care for prostate cancer
survivors in the State of Michigan to the following question: Do you feel it is appropriate for
you to provide care related to the prostate cancer and/ or treatment complications or do you
feel it is more appropriate for the treating physician to take care of such issues?
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Table 1
Characteristics of participating primary care providers and their practices
Characteristic Value
Gender (%)
    Female 46.3
    Male 53.7
Age
    Median (range, years) 50 (24-88)
    Over 45 years (%) 64.8
Years since graduating medical program (%)
    10 or less 25.5
    11 to 20 26.4
    21 to 30 29.6
    Greater than 30 18.5
Race (%)
    White/Caucasian 83.8
    Asian or Pacific Islander 7.3
    Black/African American 2.9
    Middle Easterner 1.9
    Hispanic 1.5
    Other 2.6
Medical practice type (%)
    Single specialty group practice 36.7
    Solo private practice 23.3
    Multi-specialty group 13.5
    Teaching facility 12.2
    Other 11.8
    Urgent care 2.6
Affiliated with a cancer center (%)
    Yes 26.2
    No 73.8
Distance from nearest cancer center (%)
    <5 miles 50.9
    5-10 miles 17.1
    10-20 miles 14.2
    >20 miles 17.9
Number of patients treated monthly (%)
    <200 36.0
    201-399 28.5
    400-499 22.5
    500-599 7.7
    600-999 4.5
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Characteristic Value
    >999 0.7
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Table 2
Comfort levels of primary care providers with managing prostate cancer treatment side effectsa,b
Side effect Very uncomfortable (%) Somewhat comfortable (%) Very comfortable (%) p -value
Urinary incontinence 0.09
Physician 12.2 75.6 12.2
Nurse practitioner 19.2 73.1 7.7
Physician assistant 21.8 65.5 12.7
Impotence 0.02
Physician 10.6 68.2 21.2
Nurse practitioner 19.2 65.4 15.4
Physician assistant 21.8 61.8 16.4
Bowel problems 0.01
Physician 10.0 69.8 20.2
Nurse practitioner 19.2 59.6 21.2
Physician assistant 21.8 67.3 10.9
Psychosocial concerns 0.02
Physician 9.0 56.5 34.5
Nurse practitioner 17.3 46.2 36.5




Physician includes allopathic (MD) and osteopathic physicians (DO)
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